Q1 2019 13F Holders as of 31 Mar 2019
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
388,311,585
-
Total 13F shares
-
79,523,801
-
Share change
-
+4,731,548
-
Total reported value
-
$1,604,234,442
-
Put/Call ratio
-
99%
-
Price per share
-
$20.35
-
Number of holders
-
101
-
Value change
-
+$101,479,383
-
Number of buys
-
66
-
Number of sells
-
39
Institutional Holders of Moderna, Inc. - Common Stock (MRNA) as of Q1 2019
As of 31 Mar 2019,
Moderna, Inc. - Common Stock (MRNA) was held by
101 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
79,523,801 shares.
The largest 10 holders included
Viking Global Investors LP, FMR LLC, Artal Group S.A., BB BIOTECH AG, FIDUCIARY TRUST CO, MORGAN STANLEY, WELLINGTON MANAGEMENT GROUP LLP, BAILLIE GIFFORD & CO, WADDELL & REED FINANCIAL INC, and Theleme Partners LLP.
This page lists
101
institutional shareholders reporting positions in this security
for the Q1 2019 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.